Skip to main content

Summary

for people ages 18 years and up (full criteria)
healthy people welcome
at San Francisco, California
study started
estimated completion:

Description

Summary

The goal of this study is to visualize biodistribution of a PET tracer called [18F]F-AraG through time in healthy human volunteers.

Official Title

Study of the Kinetics, Dosimetry and Safety of [18F]F-AraG, a Positron Emission Tomography Tracer for Imaging the Activation of the Immune System in Healthy Humans

Details

A positron emission tomography (PET) imaging tracer will be intravenously injected into healthy human volunteers who provide informed consent. Following injection of this tracer each volunteer will have four whole-body PET scans inside a PET scanner to obtain images of tracer biodistribution at four different time points. This will allow studying the kinetics of the tracer as well analysis of tracer dosimetry. Safety of the tracer will also be analyzed in each volunteer.

Keywords

Cancer Positron Emission Tomography Cancer Immunotherapy

Eligibility

You can join if…

Open to people ages 18 years and up

  • Healthy human subjects without history of chronic disease or at present an acute disease will be included.
  • Ability to abide by the study conditions is also a requirement for inclusion.

You CAN'T join if...

  • Individuals under the age of 18 years and pregnant women will be excluded from the[18F]F-AraG imaging studies.
  • Women who are breast-feeding will be excluded from the study.
  • Individuals unable to provide informed consent will be excluded.

Location

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
CellSight Technologies, Inc.
Links
cellsighttech.com
ID
NCT02323893
Phase
Phase 1
Lead Scientist
Benjamin Franc
Study Type
Interventional
Last Updated
May 1, 2017
I’m interested in this study!